1/39
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
Hypersensitivites:
disorders caused by inappropriately vigorous innate or adaptive immune responses to non-threatening antigens
What are the hypersensitivity categories?
Immediate, which manifest quickly usually due to antibody-antigen reactions and delayed-type which take 1-3 days to manifest and are generally caused by T cell reactions
How are the types of hypersensitivity grouped?
into four types based on the immune components that cause them and how they induce damage
Type I hypersensitivity name, immune mediator, mechanism, and examples
allergy and atopy
IgE
Ag induces cross linking of IgE bound to mast cells and basophils with release of vasoactive mediators
systemic or localized anaphylaxis such as hay fever, asthma, allergies, and eczema
Type II hypersensitivity name, immune mediator, mechanism, and examples
antibody-mediated hypersensitivity
IgG or IgM
Ab directed against cell surface antigens mediates cell destruction via complement activation or ADCC. RBCs are common targets
blood transfusion reactions or autoimmune hemolytic anemia
Type III hypersensitivity name, immune mediator, mechanism, and examples
Immune complex-mediated hypersensitivity
immune complexes
Ag-Ab complexes deposited in various tissues induce complement activation and an ensuing inflammatory response mediated by massive infiltration of neutrophils
rheumatoid arthritis, lupus, or serum sickness
Type IV hypersensitivity name, immune mediator, mechanism, and examples
delayed-type hypersensitivity
T cells
sensitized T cells release cytokines that activate macrophages or TC cells which mediate direct cellular damage
contact dermatitis and graft rejections
Atopic
individuals that produce IgE against common environmental antigens
Mechanism of type I hypersensitivity
IgE antibodies cross link FcεRIs leading to degranulation. Granule contents released include histamine, heparin, proteases, leukotrienes, prostaglandins, and chemokines that act on surrounding tissues and cells causing symptoms.
FcεR I
high affinity IgE receptors on the surface of innate immune cells that are responsible for most allergy symptoms.
How does IgE signal through FcεR I
IgE binding FcεRIs triggersn Lyn to phosphorylate ITAMs and activate Syk. Syk activates PKC and MAPK signaling pathways that lead to allergic effects
IgE receptor signaling regulation
Mast cells express both FcεRI (activating) and FcyRIIB (inhibiting) IG receptors. If a cell binds IgE and IgG, the inhibiting signal from IgG wins.
FcεR II
the low affinity IgE receptor that regulates IgE production by B cells. It may be membrane bound or soluble and can also bind CD21.
Classifications of inflammatory mediators
primary mediators: performed and stored in granules, includes histamine, proteases, ECF, NCF, and heparin
secondary mediators: synthesized after target-cell activation or released by membranes phospholipid breakdown during degranulation, includes PAF, leukotrienes, prostaglandins, bradykinin, cytokines, and chemokines
Histamine formation and receptors:
formed by decarboxylation of histidine amino acid and accounts for approximately 10% of granule weight
binds to H1, H2, H3, or H4
H1 receptor
binding induces contraction of intestinal and bronchial smooth muscles, increased permeability of venules, and mucous secretion
H2 receptor
binding increases vasopermeability and vasodilation, stimulate exocrine glands, and increases stomach acid. Also suppresses degranulation of mast cells/ basophils in a negative feedback loop
H3 receptor
is less involved in type 1 hypersensitivity and modulates neurotransmitter activity in the CNS
H4 receptor
mediates mast cell chemotaxis
Leukotrienes and protaglandin formation
formed when membranes phospholipids are enzymatically cleaved and are more potent than histamine. Leukotrienes are major causes of asthma symptoms
Cytokines and chemokines formation
release by mast cells and basophils
IL-4 and IL-13
stimulate TH2 responses to increase IGE production by B cells
IL-5
recruits and activates eosinophils
IL-8
acts as a chemotactic factor attracting other immune cels
IL-9
increases mast cell number and activity
TNF-α
may contribute to shock in systemic anaphylaxis
GM-CDF
stimulates production and activation of myeloid cells
Type IV
purely cell mediated, T cell reaction that requires a 1-2 day delay
Most common example of Type IV hypersensitivty reaction?
Poison Ivy contact dermatitis, which affects 50-70% of adults in the US
Initiation of Type IV reaction
the initiation of a type IV response involves sensitization by an antigen. This initial exposure triggers production of a T cell response (TH1)
Effector phase of a type IV response
Second exposure to antigen triggers production of TH1 inflammatory cytokines that recruit and help activate macrophages. This make take 24 hours to appear after secondary exposure.
TB example of type IV reaction
There is a prolonged inability to clear the Ag that results in the formation of destruction multinucleate giant cells and granulomas
DTH reaction detection
DTH reactions are detected by a skin test, which is performed by injecting a small amount of Ag under the skin. Positive- a red slightly swollen/ firm lesion appears within 48-72 hours.
Contact dermatitis
sensitization can occur if a reactive chemical compound (urushiol) binds to the skin proteins. These modified proteins are then presented to the T cells, causing a strong cell-mediated response against the skin cells that creates blister-like lesions and rashes.
Chronic inflammation causes
infectious conditions, physical damage, obesity, and diabetes.
Chronic inflammation consequences
tissue changes: cell death, scarring
metabolic changes: impaired insulin signaling, T2DM
other conditions: organ failure, heart disease, Alzheimers, cancer
Explain chronic inflammation due to infection
Continual microbial invasion can induce chronic inflammation such as gun disease or un-healed wounds.
Explain noninfectious causes of chronic inflammation
physical damage can release DAMPs which can lead to tumors, autoimmune disease, heart disease, or obesity